CancerLinQ LLC, an initiative of the American Society of Clinical Oncology, announced a long-term partnership with FDA that will rely on cancer patient information and big data analytics to examine the real-world use of emerging and newly approved cancer therapies.
Up to 80% of adolescents and young adults with cancer are affected by reduced fertility after treatment—but only 50% received oncofertility counseling and preservation options prior to beginning treatment.
